Lyra Therapeutics (LYRA) to Release Quarterly Earnings on Thursday

Lyra Therapeutics (NASDAQ:LYRA) will likely be announcing its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($0.12) per share and revenue of $0.21 million for the quarter.

Lyra Therapeutics Price Performance

Lyra Therapeutics stock opened at $0.18 on Thursday. Lyra Therapeutics has a 12 month low of $0.16 and a 12 month high of $6.79. The business has a 50 day simple moving average of $0.20 and a 200-day simple moving average of $0.22. The stock has a market capitalization of $11.90 million, a PE ratio of -0.12 and a beta of -0.18.

About Lyra Therapeutics

Lyra Therapeutics, Inc, a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration.